Showing results (101-110 of 149) with videos related to
Sort By:
Pageof 15
Neurology|December 13, 2019
Targeted next-generation sequencing panels in the diagnosis of Charcot-Marie-Tooth diseaseAndrea Cortese, Janel E Wilcox, James M Polke, et al.Journal of the Neurological Sciences|November 3, 2019
Routine blood monitoring in maintenance immunoglobulin treatment of inflammatory neuropathy: Is it clinically relevant?R Keh, A Kahlil, L Nihoyannopoulos, et al.Journal of Virology|November 13, 1999
Effect of lamivudine on human T-cell leukemia virus type 1 (HTLV-1) DNA copy number, T-cell phenotype, and anti-tax cytotoxic T-cell frequency in patients with HTLV-1-associated myelopathyG P Taylor, S E Hall, S Navarrete, et al.Neuromuscular Disorders : NMD|March 16, 2013
Rapidly progressive asymmetrical weakness in Charcot-Marie-Tooth disease type 4J resembles chronic inflammatory demyelinating polyneuropathyEllen Cottenie, Manoj P Menezes, Alexander M Rossor, et al.Brain : a Journal of Neurology|June 20, 2023
Post-transcriptional microRNA repression of PMP22 dose in severe Charcot-Marie-Tooth disease type 1Menelaos Pipis, Seongsik Won, Roy Poh, et al.Brain : a Journal of Neurology|March 14, 2024
Whole genome sequencing increases the diagnostic rate in Charcot-Marie-Tooth diseaseChristopher J Record, Menelaos Pipis, Mariola Skorupinska, et al.Neurology|March 12, 2017
Mutations in noncoding regions of <i>GJB1</i> are a major cause of X-linked CMTPedro J Tomaselli, Alexander M Rossor, Alejandro Horga, et al.Neurology|November 27, 2002
Chromosome 3 linked frontotemporal dementia (FTD-3)S Gydesen, J M Brown, A Brun, et al.Brain : a Journal of Neurology|March 26, 2019
Gene replacement therapy in a model of Charcot-Marie-Tooth 4C neuropathyNatasa Schiza, Elena Georgiou, Alexia Kagiava, et al.Annals of the New York Academy of Sciences|May 20, 2000
Hereditary vascular dementia linked to notch 3 mutations. CADASIL in British familiesN J Thomas, C M Morris, F Scaravilli, et al.Pageof 15